{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Although neither of the provided abstracts directly examines DLEU1‐AS1, they do highlight key mechanisms by which long noncoding RNAs (lncRNAs) can influence disease processes. In Abstract"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ", a different lncRNA—LINC01308—is found to be highly expressed in ovarian cancer, where its overexpression correlates with enhanced metastatic potential and poorer patient survival. Mechanistically, LINC01308 promotes tumor cell migration and invasion by targeting and downregulating miRNA‑506, thus acting as an oncogenic driver. In contrast, Abstract"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "investigates genetic predispositions to stress cardiomyopathy, revealing a high rate of rare copy number variants impacting genes of cardiac relevance; although no lncRNA is directly implicated in this study, the findings underscore the broader impact of noncoding genomic elements on disease pathophysiology. \n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Together, these studies illustrate how regulatory noncoding RNAs—analogous in function to DLEU1‐AS1—can modulate critical cellular pathways in both oncologic and cardiac settings. The ovarian cancer study (1) demonstrates that lncRNAs may drive malignant behaviors through microRNA sponging, while the cardiomyopathy study (2) reflects the complex genomic landscape that can underlie sporadic disease manifestations. Insights from such research may provide a conceptual framework for exploring DLEU1‐AS1’s potential roles in disease, pending direct experimental evidence.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Y-Y Zhang, P Li, M-Z Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LINC01308 accelerates the malignant progression of ovarian cancer by binding to miRNA-506."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201904_17685"}], "href": "https://doi.org/10.26355/eurrev_201904_17685"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31081077"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31081077"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Cameron J Lacey, Kit Doudney, Paul G Bridgman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Copy number variants implicate cardiac function and development pathways in earthquake-induced stress cardiomyopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-018-25827-5"}], "href": "https://doi.org/10.1038/s41598-018-25827-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29765130"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29765130"}]}]}]}